It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes multiple pregnancy compared with placebo/ no treatment (very low certainty).
It is very uncertain whether nonsteroidal anti‐inflammatory drugs changes side effects compared with placebo/ no treatment (very low certainty).
Blood pressure‐lowering drugs (BPLDs) probably leads to lower recurrent stroke of any type compared with placebo or no treatment (moderate certainty).
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in major vascular event (composite of non‐fatal stroke, non‐fatal… compared with placebo or no treatment (high certainty).
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in myocardial infarction compared with placebo or no treatment (high certainty).
Blood pressure‐lowering drugs (BPLDs) leads to lower vascular death compared with placebo or no treatment (high certainty).
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in death by any cause compared with placebo or no treatment (moderate certainty).
Blood pressure‐lowering drugs (BPLDs) showed no clear difference in dementia compared with placebo or no treatment (high certainty).
It is very uncertain whether nonsteroidal anti‐inflammatory drugs (NSAIDs) changes AKI within 30 days of surgery compared with placebo or no treatment (very low certainty).
It is very uncertain whether nonsteroidal anti‐inflammatory drugs (NSAIDs) changes RRT within 30 days of surgery compared with placebo or no treatment (very low certainty).
It is very uncertain whether nonsteroidal anti‐inflammatory drugs (NSAIDs) changes death (all causes) compared with placebo or no treatment (very low certainty).
It is very uncertain whether nonsteroidal anti‐inflammatory drugs (NSAIDs) changes length of hospital stay compared with placebo or no treatment (very low certainty).
Summary of findings: lamotrigine showed no clear difference in treatment withdrawal compared with placebo (moderate certainty).
Perampanel add‐on may leads to higher treatment withdrawal due to any reason compared with placebo (low certainty).
Perampanel add‐on may leads to higher treatment withdrawal due to adverse effects compared with placebo (low certainty).
Pregabalin showed no clear difference in treatment withdrawal for any reason compared with active comparators (low certainty).
Pregabalin probably leads to higher treatment withdrawal for any reason compared with placebo (moderate certainty).
Pregabalin probably leads to higher treatment withdrawal due to adverse effects compared with placebo (moderate certainty).